Expression of PKM2 Y105F mutant in H1299 cells leads to decreased proliferation under hypoxic conditions, increased oxidative phosphorylation and reduced.

Slides:



Advertisements
Similar presentations
Nicotinamide Phosphoribosyltransferase: A Potent Therapeutic Target in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor-Gene Mutation 
Advertisements

Hypoxia increases IL-32 expression in an HIF1α-dependent manner.
SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models. SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models.
Inhibition of FGFR fusion kinase activity repressed tumor growth in a mouse xenograft model. Inhibition of FGFR fusion kinase activity repressed tumor.
CDK2 is highly expressed in colon cancer cells and curcumin selectively suppresses HCT116 cell proliferation. CDK2 is highly expressed in colon cancer.
Dual Role of Apoptosis-Associated Speck-Like Protein Containing a CARD (ASC) in Tumorigenesis of Human Melanoma  Weimin Liu, Yuchun Luo, Jeffrey H. Dunn,
Induction of cell filamentation by Fic-1.
Volume 8, Issue 6, Pages (December 2005)
Volume 44, Issue 6, Pages (December 2011)
Volume 53, Issue 4, Pages (February 2014)
In vivo responses of AMLMLL to ATRi.
S534 phosphorylation affects DNA binding and gene expression by NF-κB at late time points through regulation of p65 stability. S534 phosphorylation affects.
The STM1787 promoter in Salmonella is rapidly activated in vivo by the tumor microenvironment. The STM1787 promoter in Salmonella is rapidly activated.
Identification of TLOC1 and SKIL as tumor driver genes in 3q26.
HER2 mutants V777L, G309A, D769H formed tumors more rapidly than HER2 WT. A, a total of 0.5 × 106 cells of NIH3T3 expressing either HER2 WT or mutant were.
Inhibition of FGFR signaling and tumor growth in SNU-16 xenograft model by administration of E7090. Inhibition of FGFR signaling and tumor growth in SNU-16.
Hypoxic Regulation of Glutamine Metabolism through HIF1 and SIAH2 Supports Lipid Synthesis that Is Necessary for Tumor Growth  Ramon C. Sun, Nicholas C.
Volume 19, Issue 3, Pages (March 2011)
Specific depletion of TFH and LCMV-specific CD4 T cells.
Volume 10, Issue 8, Pages (March 2015)
The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma cells. The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma.
Antitumor effect of local cancer immunotherapy treatment toward distant B16F10 tumors. Antitumor effect of local cancer immunotherapy treatment toward.
PKA phosphorylates Thr63 and Ser692 to increase HIF-1α stability.
The TGF-β pathway is activated in the skin after C
LV activation of DCs and subsequent CD8+ T cell priming are dependent on STING and cGAS but not on MyD88, TRIF, or MAVS. LV activation of DCs and subsequent.
PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD, leading to mTORC2 activation. PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD,
Nicotinamide Phosphoribosyltransferase: A Potent Therapeutic Target in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor-Gene Mutation 
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance  Valeria R. Fantin, Julie St-Pierre,
Overexpression of HGF decreases MET protein levels.
Role of HER2 in mediating acquired resistance to EGFR inhibition.
Existence of a nuclear NFATc1–STAT3 complex in pancreatic cancer.
The role of SRC-C3G-RAP1 signaling in transformation induced by CRKL
ONC201 activates the ATF4 pathway through the eIF2α kinases HRI and PKR. ONC201 activates the ATF4 pathway through the eIF2α kinases HRI and PKR. (A) Western.
Src acetylation is critical for its tumorogenesis property.
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia  Jung-whan Kim, Irina Tchernyshyov,
Combined HDAC and mTOR inhibitors kill NF1-mutant malignancies in vitro and in vivo. Combined HDAC and mTOR inhibitors kill NF1-mutant malignancies in.
Fcp1 CTD phosphatase affects a broad range of transcripts in the +N and -N media. Fcp1 CTD phosphatase affects a broad range of transcripts in the +N and.
AMPK-mediated mTORC2 signaling does not require mTOR Ser1261phosphorylation. AMPK-mediated mTORC2 signaling does not require mTOR Ser1261phosphorylation.
Fig. 5 Hypoxic tumors from obese mice associate with increased production of IL-6 by adipocytes and myeloid cells. Hypoxic tumors from obese mice associate.
Figure 4 DNM1 mutations affect protein levels and self-dimerization (A) HeLa cells were transfected with green fluorescent protein (GFP)-tagged mutant.
Antitumor effect of local cancer immunotherapy treatment in various tumor models. Antitumor effect of local cancer immunotherapy treatment in various tumor.
Administration of necroptosis-targeting AAVs in conjunction within vivo promotes durable tumor clearance. Administration of necroptosis-targeting AAVs.
Immune-mediated tumor control by necroptotic cells requires NF-κB activation within dying cells but not MLKL-mediated cell lysis and DAMP release. Immune-mediated.
Tumor control by necroptotic cells requires BATF3+cDC1 and CD8+leukocytes. Tumor control by necroptotic cells requires BATF3+cDC1 and CD8+leukocytes. (A)
ONC201 activates the ISR. ONC201 activates the ISR. (A) Western blotting analysis for ATF4, CHOP, ATF3, and TRB3 on lysates from HCT116 cells cultured.
CO inhibits H2S generation through sGC-dependent cGMP production.
Global analysis of RV[S/T]F motif phosphorylation during mitosis.
Effects of NAT10 inhibition or depletion on gene expression.
Inhibition of CDK9 by UNC drives MYC loss.
The Tumor Suppressor PP2A Aβ Regulates the RalA GTPase
MYC degradation screen identifies a compound that stabilizes MYC protein. MYC degradation screen identifies a compound that stabilizes MYC protein. (A)
by Jianping Guo, Abhishek A
Fig. 2 TGF-β1 signaling drives fibrosis in Neu1−/− muscle, which is rescued by AAV-mediated gene therapy. TGF-β1 signaling drives fibrosis in Neu1−/− muscle,
PKM2 is tyrosine phosphorylated and inhibited by FGFR1 in cancer cells with oncogenic or overexpressed FGFR1. PKM2 is tyrosine phosphorylated and inhibited.
S-Affs colocalize with SUMO in mammalian cells.
Gramicidin A (GA) decreases HIF protein expression in RCC cells.
The effect of IAA on tumor growth in an SK-MEL-28 xenograft model.
by Kevin J. Paavola, Harwin Sidik, J
PD and efficacy of AZD4785 in KRAS mutant lung cancer xenograft models
N-3 PUFAs promote endometrial cancer cell apoptosis in vitro and in vivo. n-3 PUFAs promote endometrial cancer cell apoptosis in vitro and in vivo. HEC-1-A.
CDCP1 links Ras and SFK signaling and regulates anoikis resistance, cell migration, and invasion in NSCLC cells. CDCP1 links Ras and SFK signaling and.
Volume 3, Issue 1, Pages (January 2003)
Comparison of in vivo activity of 4D5scFvZZ and 4D5scFv.
Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and HAL-treated xenografts. Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and.
Increased growth factor receptor expression in lungs and tumors of hypoxic mice. Increased growth factor receptor expression in lungs and tumors of hypoxic.
Regulation of NUAK1 by NRF2 and ROS
Acute circadian disruption alters ILC3 cytokine secretion.
AXL knockout does not prevent dormancy.
DHA and dietary n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in xenograft models. DHA and dietary n-3 PUFAs inhibit endometrial cancer.
CCR6 is dispensable for expansion of innate TCRαβ+ cells in oral candidiasis. CCR6 is dispensable for expansion of innate TCRαβ+ cells in oral candidiasis.
Presentation transcript:

Expression of PKM2 Y105F mutant in H1299 cells leads to decreased proliferation under hypoxic conditions, increased oxidative phosphorylation and reduced tumor growth. Expression of PKM2 Y105F mutant in H1299 cells leads to decreased proliferation under hypoxic conditions, increased oxidative phosphorylation and reduced tumor growth. (A) Rescue expression of mPKM2 Y105F in H1299 cells results in reduced cell proliferation under hypoxic conditions (1%) but not at normal oxygen tension (normoxic; 17% oxygen) compared with cells expressing PKM2 WT or Y390F mutant. Cell proliferation was determined by the increase in cell number 96 hours after seeding compared to that at seeding for each cell line (T = 0). Error bars represent the means ± SD from three independent experiments. (B) Y105F rescue H1299 cells have a higher rate of oxygen consumption than do cells with mPKM2 WT. (C) Y105F rescue H1299 cells show significantly reduced lactate production under normoxia. (D) Proliferation (left), oxygen consumption rate (middle), and intracellular ATP concentration (right) of Y105F rescue H1299 cells are significantly decreased relative to cells expressing PKM2 WT or the Y390F mutant when treated with oligomycin. (E) Upper left: Tumors (indicated by red arrows) in representative nude mice injected with mPKM2 WT H1299 cells on the left flank and mPKM2 Y105F H1299 cells on the right flank. Lower left: Dissected tumors from the depicted nude mice. Right: expression of Flag-tagged mPKM2 WT and Y105F detected by immunoblotting in injected rescue cells (upper) and tumor lysates (lower). Phosphorylation of PKM2 at Y105 was detected in tumors formed by cells expressing mPKM2 WT, but not in tumors derived from Y105F-expressing cells. (F) H1299 cells expressing PKM2 Y105F show significantly reduced tumor formation in xenograft nude mice (P value was determined by the paired Student’s t test). Taro Hitosugi et al., Sci. Signal. 2009;2:ra73 Copyright © 2009, American Association for the Advancement of Science